The Global Pharmaceutical Gelatin Market was valued at USD 811.60 million in 2023 and is projected to reach USD 1,302.89 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period (2025-2032). This growth is driven by increasing demand for capsule-based drug delivery systems, rising pharmaceutical R&D investments, and expanding applications in vaccine stabilization and wound care.
As the pharmaceutical industry continues to evolve with patient-centric formulations and biologics advancement, gelatin remains a foundational biomaterial supporting diverse therapeutic applications. In this blog, we profile the Top 10 Companies in the Pharmaceutical Gelatin Industry—a mix of established manufacturers and innovative specialists shaping the future of pharmaceutical-grade gelatin.
🔟 1. Rousselot (Darling Ingredients)
Headquarters: Son, Netherlands
Key Offering: Pharma-Gel™ Range, Capsugel® Solutions
Rousselot leads the global pharmaceutical gelatin market through its specialized Pharma-Gel™ portfolio, catering to hard capsules, soft gels, and tablet coatings. The company maintains BSE-free certified supply chains across its 27 production sites.
Innovation Focus:
-
Plant-based gelatin alternatives under development
-
Customized gelatin solutions for mRNA vaccine stabilization
-
Global capacity expansion in Asia and North America
Download FREE Sample Report: Pharmaceutical Gelatin Market – View in Detailed Research Report
9️⃣ 2. Gelita AG
Headquarters: Eberbach, Germany
Key Offering: GELITA® Medical Gelatins, Cold Water-Soluble Variants
Gelita AG specializes in high bloom strength gelatins for pharmaceutical applications, holding 18% market share in Europe. Their products meet EP/USP/JP pharmacopeia standards for critical medical applications.
Innovation Focus:
-
Patented hydrolysis technology for controlled molecular weight
-
Specialized gelatins for hemostatic sponges
8️⃣ 3. PB Gelatins (Tessenderlo Group)
